Literature DB >> 19364629

Physical activity, eccentric contractions of plantar flexors, and neurogenesis: therapeutic potential of flat shoes in psychiatric and neurological disorders.

Jarl Flensmark1.   

Abstract

Using flat shoes with no heels results in stronger eccentric contractions of plantar flexors, which stimulate the rostral parts of the cerebellar vermis. The stimulation inhibits the limbic structures and increase neurogenesis. Physical activity often involves walking. Eccentric contractions during dorsal flexion of the plantar flexors in the stance phase of walking give rise to tension signals from Golgi tendon organs. The signals from the eccentric contractions are brought to the rostral parts of the cerebellar vermis. Electrical stimulation of the vermis inhibits the limbic structures and increases neurogenesis, and so do the signals from eccentric contractions. The use of heeled shoes results in less eccentric contractions with decreased neurogenesis. People in the Western World wore heeled shoes from the beginning of the 17th century, and, because of the decreased neurogenesis, the prevalence of diseases such as depression, epilepsia, Alzheimer's disease, Parkinson's disease, schizophrenia, diabetes, and myopia increased. Use of flat shoes produces stronger eccentric contractions and increases neurogenesis. This would lead to better protection from a range of diseases. Even therapy is possible.

Entities:  

Mesh:

Year:  2009        PMID: 19364629     DOI: 10.1016/j.mehy.2009.03.009

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  2 in total

1.  Uphill and Downhill Walking in Multiple Sclerosis: A Randomized Controlled Trial.

Authors:  Afshin Samaei; Amir Hoshang Bakhtiary; Abdolhamid Hajihasani; Elham Fatemi; Fatemeh Motaharinezhad
Journal:  Int J MS Care       Date:  2016 Jan-Feb

Review 2.  Cognitive reserve and Alzheimer's disease.

Authors:  Wei Xu; Jin-Tai Yu; Meng-Shan Tan; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.